title: AASLD guidelines for treatment of chronic hepatitis B.
authors.affiliation: University of California San Francisco, San Francisco, CA.
authors.forename: Norah A
authors.initials: NA
authors.lastname: Terrault
authors.affiliation: Ochsner Medical Center, New Orleans, LA.
authors.forename: Natalie H
authors.initials: NH
authors.lastname: Bzowej
authors.affiliation: Corporal Michael J. Crescenz VA Medical Center & University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
authors.forename: Kyong-Mi
authors.initials: KM
authors.lastname: Chang
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Jessica P
authors.initials: JP
authors.lastname: Hwang
authors.affiliation: Boston Children's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Maureen M
authors.initials: MM
authors.lastname: Jonas
authors.affiliation: Mayo Clinic, Rochester, MN.
authors.forename: M Hassan
authors.initials: MH
authors.lastname: Murad
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006511:Hepatitis B Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D014766:Viremia / Q000821:virology
chemical_list: D000998:Antiviral Agents; D006511:Hepatitis B Antigens